2007
2022
Cancer Center Amsterdam
-
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study
Kersten, M. J., Amaador, K., Minnema, M. C., Vos, J. M. I., Nasserinejad, K., Kap, M., Kastritis, E., Gavriatopoulou, M., Kraan, W., Chamuleau, M. E. D., Deeren, D., Tick, L. W., Doorduijn, J. K., Offner, F., Böhmer, L. H., Liu, R. D., Pals, S. T. & Dimopoulos, M. A., 1 Jan 2022, In: Journal of clinical oncology. 40, 1, p. 40-51 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Discriminating between Waldenström macroglobulinemia and marginal zone lymphoma using logistic LASSO regression
Amaador, K., Vos, J. M. I., Pals, S. T., Kraan, W., Dobber, J. A., Minnema, M. C., Koene, H. R., de Bruin, P. C., Zwinderman, A. H. & Kersten, M. J., 2022, In: Leukemia & lymphoma. 63, 5, p. 1070-1079 10 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Correction to: The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma (Journal of Hematology & Oncology, (2021), 14, 1, (11), 10.1186/s13045-021-01031-3)
Ren, Z., Lantermans, H., Kuil, A., Kraan, W., Arenzana-Seisdedos, F., Kersten, M. J., Spaargaren, M. & Pals, S. T., 1 Dec 2021, In: Journal of hematology & oncology. 14, 1, 29.Research output: Contribution to journal › Comment/Letter to the editor › Academic
- All publications